Pharmafile Logo

The future of dementia and the important role of healthcare communication in raising awareness

At Bedrock Healthcare Communication we are proud to help spread awareness of dementia with the ultimate goal to improve the lives of patients and carers

This week in the UK marks Dementia Action Week, a national eventorganised by the Alzheimer’s Society that sees the public coming together to take action to improve the lives of people affected by dementia.

Dementia is a growing challenge and has become one of the most important health and social care issues in the UK. Today there are approximately 850,000 people living with the disease in the UK and this number is predicted to double by 2040 with a current economic cost estimated at £23 billion a year and predicted to triple by 2040.

- PMLiVE

While Alzheimer’s disease it the most common and well-known cause of dementia, with over 10 million cases globally, it is not the only one. There are different diseases that can cause dementia. These involve protein build-up and/or reduced blood flow in the brain that ultimately cause a progressive cognitive decline that can manifest as memory loss, language deficit and changes in mood and behaviour, among others.

There are few existing treatments for dementia and research remains pivotal.Prescribers and patients would of course welcome more effective and longer-lasting symptomatic treatments. Patients would benefit most from a disease-slowing or modifying therapy but symptomatic treatments with improved clinical profiles would also make a difference to their lives.

Progress was made in February 2018, when the FDA released a draft guidance document categorising Alzheimer’s disease into stages that define preclinical and prodromal disease based on biomarker, cognitive, and functional attributes. This allows for an accelerated approval for treatments based on biomarkers that are reasonably likely to predict clinical benefit. While the pharmaceutical industry continues its search for treatments there is a need to educate healthcare professionals on the latest developments in biomarker research and how these can be used in clinical practice.

At Bedrock Healthcare Communications, we are proud and passionate to share our expertise in neuroscience. We in medical communication across neurological diseases every day, and this Dementia Action Week we are committed to help raise awareness and truly make a difference to all those affected by this condition.

If you share our passion, visit bedrock-health.com and start a conversation with us.

REFERENCES:

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

The story behind Chloe Mitchell

From patient safety to a rising star in the Medical Communications world

Bedrock keep it in the family

Recent filming project really is a family affair

Bedrock celebrate inspirational women

The company is keen to champion its women’s achievements

Bedrock strengthens Scientific Services team

The appointment of a Head of Scientific Services will reinforce the company’s core medical communications offering

Bedrock supports international kidney charity Transplant Links Community (TLC) with its major fund-raising activities

Bedrock Healthcare Communications, through its 2018 pro-bono charity support programme is actively working with important international charity Transplant Links Community to spread the word about its celebrity supported Art Auction,...

Bedrock scoops top prizes at Digital Awards

Bedrock scoops top prizes at PM Society Digital Awards 2018 recognising creativity in medical education, corporate communications and film making

In Memory

In Memory is a pioneering new short film that exemplifies Bedrock Multimedia’s industry leading approach to healthcare edutainment. It provides a captivating example of how film can be used to...

Millefeuille

This story of hope charts Élodie’s physical and mental struggles with psoriasis and psoriatic arthritis. With a little encouragement from her friend Holly, she regains the confidence to live a...